218 related articles for article (PubMed ID: 37461351)
21. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
22. Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.
Lopalco A; Ali H; Denora N; Rytting E
Int J Nanomedicine; 2015; 10():1985-96. PubMed ID: 25792832
[TBL] [Abstract][Full Text] [Related]
23. Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells.
Ansari L; Derakhshi M; Bagheri E; Shahtahmassebi N; Malaekeh-Nikouei B
Pharm Dev Technol; 2020 Jun; 25(5):601-609. PubMed ID: 32026739
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
[TBL] [Abstract][Full Text] [Related]
25. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
26. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
27. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
28. Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc.
He Z; Zhang X; Huang J; Wu Y; Huang X; Chen J; Xia J; Jiang H; Ma J; Wu J
Oncotarget; 2016 Nov; 7(47):76635-76646. PubMed ID: 27791199
[TBL] [Abstract][Full Text] [Related]
29. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of silica nanoparticles in the human placenta.
Poulsen MS; Mose T; Maroun LL; Mathiesen L; Knudsen LE; Rytting E
Nanotoxicology; 2015 May; 9 Suppl 1(0 1):79-86. PubMed ID: 23742169
[TBL] [Abstract][Full Text] [Related]
31. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
Wang Y; Wang Y; Xiang J; Yao K
Biomacromolecules; 2010 Dec; 11(12):3531-8. PubMed ID: 21086982
[TBL] [Abstract][Full Text] [Related]
32. Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.
Fasehee H; Dinarvand R; Ghavamzadeh A; Esfandyari-Manesh M; Moradian H; Faghihi S; Ghaffari SH
J Nanobiotechnology; 2016 Apr; 14():32. PubMed ID: 27102110
[TBL] [Abstract][Full Text] [Related]
33. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
34. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application.
Jafari-Gharabaghlou D; Dadashpour M; Khanghah OJ; Salmani-Javan E; Zarghami N
Mol Biol Rep; 2023 Apr; 50(4):3023-3033. PubMed ID: 36662452
[TBL] [Abstract][Full Text] [Related]
36. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.
Valencia PM; Hanewich-Hollatz MH; Gao W; Karim F; Langer R; Karnik R; Farokhzad OC
Biomaterials; 2011 Sep; 32(26):6226-33. PubMed ID: 21658757
[TBL] [Abstract][Full Text] [Related]
37. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
38. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery.
Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z
Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214
[TBL] [Abstract][Full Text] [Related]
39. Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells.
Pillai JJ; Thulasidasan AK; Anto RJ; Chithralekha DN; Narayanan A; Kumar GS
J Nanobiotechnology; 2014 Jul; 12():25. PubMed ID: 25026938
[TBL] [Abstract][Full Text] [Related]
40. pH-Sensitive Magnetite Nanoparticles Modified with Hyperbranched Polymers and Folic Acid for Targeted Imaging and Therapy.
Rezaei SJT; Malekzadeh AM; Ramazani A; Niknejad H
Curr Drug Deliv; 2019; 16(9):839-848. PubMed ID: 31577207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
